Provider Adoption of Pneumococcal Conjugate Vaccine and the Impact of Vaccine Shortages
- 30 June 2005
- journal article
- research article
- Published by Elsevier in Academic Pediatrics
- Vol. 5 (3) , 157-164
- https://doi.org/10.1367/a04-142r.1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians.The Journal of the American Board of Family Medicine, 2003
- A Survey of Pediatricians on the Reintroduction of a Rotavirus VaccinePublished by American Academy of Pediatrics (AAP) ,2003
- Physician Perspectives Regarding Pneumococcal Conjugate VaccinePediatrics, 2002
- Pediatricians' Views on Financial Barriers and Values for Pneumococcal Vaccine for ChildrenAcademic Pediatrics, 2002
- Reimbursement for Prevnar: a modern-day version of Hercules and the Hydra.Pediatrics, 2002
- Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits?American Journal of Epidemiology, 2001
- Physicians' early challenges related to the pneumococcal conjugate vaccine.Academic Pediatrics, 2001
- The Rotavirus Vaccine's Withdrawal and Physicians' Trust in Vaccine Safety MechanismsArchives of Pediatrics & Adolescent Medicine, 2001
- Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic ProphylaxisPediatrics, 2000
- Progress in coverage with hepatitis B vaccine among US children, 1994-1997.American Journal of Public Health, 1999